Market
How many doses of the bubonic plague vaccine will Oxford/AstraZeneca produce by end of 2025?
2
Resolution / Starting Odds
Less than 1 million • 25%
1 to 5 million • 25%
5 to 10 million • 25%
More than 10 million • 25%
Production reports from AstraZeneca or Oxford University
Story
Oxford/AstraZeneca Scientists Develop Bubonic Plague Vaccine for Black Death Amid UK Stockpile Concerns
Jan 4, 2025, 06:35 PM
Scientists from Oxford University and AstraZeneca are developing a vaccine for the bubonic plague, responding to concerns about a potential superbug strain of the Black Death. Military experts have advised the UK government to stockpile supplies of this new inoculation. The initiative follows the team's previous work on the Covid-19 vaccine, highlighting ongoing efforts to prepare for emerging infectious diseases.
View original story
Similar markets
50 to 100 million doses • 25%
10 to 50 million doses • 25%
Less than 10 million doses • 25%
More than 100 million doses • 25%
More than 100 million • 25%
10 to 50 million • 25%
Less than 10 million • 25%
50 to 100 million • 25%
Less than 1 million • 25%
5-10 million • 25%
More than 10 million • 25%
1-5 million • 25%
1-3 million doses distributed • 25%
Over 5 million doses distributed • 25%
3-5 million doses distributed • 25%
0-1 million doses distributed • 25%
Less than 1 million • 25%
1 to 3 million • 25%
3 to 5 million • 25%
More than 5 million • 25%
More than 100,000 • 25%
10,000 to 50,000 • 25%
Less than 10,000 • 25%
50,001 to 100,000 • 25%
No • 50%
Yes • 50%
200,000 to 299,999 doses • 25%
100,000 to 199,999 doses • 25%
Less than 100,000 doses • 25%
300,000 or more doses • 25%
Yes • 50%
No • 50%
100,000 to 500,000 doses • 25%
Less than 100,000 doses • 25%
More than 1,000,000 doses • 25%
500,001 to 1,000,000 doses • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%